Levodopa is a synthetic amino acid and central nervous system agent widely used in the clinical management of Parkinson's disease and dopamine-responsive dystonia. As a catecholamine precursor, this prodrug… Read more























![Chemical structure of 4-O-Benzyl-N-[(benzyloxy)carbonyl]-L-dOPA methyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F105229-41-2-4-O-Benzyl-N-benzyloxycarbonyl-L-dOPA-methyl-ester.png&w=3840&q=75)






















![Chemical structure of N-[2-[4-(Acetyloxy)-3-methoxyphenyl]-1-cyano-1-methylethyl]acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F15073-74-2-N-2-4-Acetyloxy-3-methoxyphenyl-1-cyano-1-methylethylacetamide.png&w=3840&q=75)



Levodopa is a synthetic amino acid and central nervous system agent widely used in the clinical management of Parkinson's disease and dopamine-responsive dystonia. As a catecholamine precursor, this prodrug effectively crosses the blood-brain barrier to restore depleted dopamine levels. To ensure the safety and efficacy of this treatment, pharmaceutical laboratories utilize a range of analytical reference standards for quality control and method validation. This collection includes pharmacopeial and non-pharmacopeial impurities, such as degradation products and structurally related compounds, which are essential for conducting rigorous impurity profiling and stability studies. Furthermore, the catalogue features metabolites and stable isotope labelled compounds, such as deuterium-labelled analogs, which serve as critical internal standards for accurate quantification in bioanalytical assays and mass spectrometry-based research. These materials support the development of robust analytical methods throughout the drug development and manufacturing lifecycle.